SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-290892
Filing Date
2019-11-13
Accepted
2019-11-13 15:19:03
Documents
4
Period of Report
2019-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d831518d8k.htm 8-K 17947
2 EX-99.1 d831518dex991.htm EX-99.1 24684
3 EX-99.2 d831518dex992.htm EX-99.2 39958
4 GRAPHIC g831518g1113230352540.jpg GRAPHIC 7489
  Complete submission text file 0001193125-19-290892.txt   94170
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 191213481
SIC: 3841 Surgical & Medical Instruments & Apparatus